Publication | Closed Access

Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis

NutritionInterim AnalysisCardiovascular DiseasePlasma LipidMedicineNutraceutical IngredientSingle BlindHyperlipidemiaPublic HealthPharmacologyAtherosclerosisDyslipidemia